Business Description
EOM Pharmaceutical Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US4525364026
Description
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve quality of life in patients suffering from debilitating and sometimes deadly diseases. Its products have been approved in the U.S., rheumatoid arthritis, and inflammatory conditions of the gastrointestinal tract such as Crohn's Disease and Ulcerative Colitis as well as various retina disorders characterized by a breakdown of the blood-retinal barrier such as diabetic retinopathy, Aged related macular degeneration and retinal vein occlusion among others. Its pipeline includes its compound EOM613, an investigational novel dynamically dual-acting immunomodulator.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.79 | |||||
9-Day RSI | 38.29 | |||||
14-Day RSI | 41.59 | |||||
3-1 Month Momentum % | 158.22 | |||||
6-1 Month Momentum % | 46.67 | |||||
12-1 Month Momentum % | 120.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -2.91 | |||||
EV-to-EBITDA | -2.91 | |||||
EV-to-FCF | -1.51 | |||||
Earnings Yield (Greenblatt) % | -34.36 | |||||
FCF Yield % | -66.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IMUC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EOM Pharmaceutical Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.732 | ||
| Beta | -0.1287 | ||
| 3-Year Sharpe Ratio | 0.57 | ||
| 3-Year Sortino Ratio | 1.74 | ||
| Volatility % | 385.4 | ||
| 14-Day RSI | 41.59 | ||
| 14-Day ATR ($) | 0.036151 | ||
| 20-Day SMA ($) | 0.210335 | ||
| 12-1 Month Momentum % | 120.22 | ||
| 52-Week Range ($) | 0.036 - 0.3399 | ||
| Shares Outstanding (Mil) | 126.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EOM Pharmaceutical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EOM Pharmaceutical Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2020-09-16 | 0.30 (+0.00%) | ||
| 0.025:1 Stock Split | 2016-11-21 | 26.20 (-13.70%) |
Show
Entries
EOM Pharmaceutical Holdings Inc Frequently Asked Questions
What is EOM Pharmaceutical Holdings Inc(IMUC)'s stock price today?
The current price of IMUC is $0.13. The 52 week high of IMUC is $0.34 and 52 week low is $0.04.
When is next earnings date of EOM Pharmaceutical Holdings Inc(IMUC)?
The next earnings date of EOM Pharmaceutical Holdings Inc(IMUC) is .
Does EOM Pharmaceutical Holdings Inc(IMUC) pay dividends? If so, how much?
EOM Pharmaceutical Holdings Inc(IMUC) does not pay dividend.
Guru Commentaries on OTCPK:IMUC
No articles.
Press Release
Articles on EOM Pharmaceutical Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers